Pediatric Working Group 

Mission/Objectives

  • Become a catalyst for advancing science and technology related to pediatric formulation development
     
  • Collaboratively advance pediatric formulation development and regulatory harmonization globally
     
  • Share best practices and standardization, publish and consider new mechanisms for collaboration
     
  • Build holistic understanding of patient, caregiver, and regulatory needs and challenges

Webinar Series

This webinar series also serves as an online platform to promote pre-competitive interaction and collaboration among industry-peers.  We encourage you to share this with interested colleagues and remember, this is a public series - you do not need to be an IQ member to register for this webinar. Feel free to copy link and share with your non-IQ member peers.

Register or view a previous webinar now by clicking the relevant link below.

 

            2021

 

Webinar Title

Speaker/Affiliation

Date

Access Link

 

Approaches for Sensory Evaluation of Medicine Palatability

Alexander Bachmanov 
GlaxoSmithKline

01 April 

VIEW ON DEMAND

 

Artificial Intelligence/Machine Learning

Luis  Ahumada
Johns Hopkins All Children's Hospital

06 May 

REGISTER HERE

 

Excipient selection for pediatric drug product – A benefit/risk assessment approach

Anjali Agrawal
Bristol Myers Squibb

03 June 

REGISTER HERE

 

Pediatric Biopharmaceutics – Considerations for Bioavailability and Bioequivalence Studies of Age Appropriate Pediatric Formulations

Jack Cook
Pfizer

02 September 

REGISTER HERE

 

Regulatory perspective on pediatric drug development
 

Pediatric Webinar (Title TBD)

Pediatric Webinar (Title TBD)

Jian Wang
FDA

TBD

Hari Sachs
FDA (Retired)

07 October
 

04 November

02 December

REGISTER HERE
 

REGISTER HERE

REGISTER HERE

 


2020

Webinar Title

Speaker / Affiliation

 

Access Link

Pediatric Dosage Forms "Out in the Wild" - What Really Happens in Clinical Practice

Dr. Rachel Meyers
Saint Barnabas Medical Center / Rutgers University

 

VIEW ON DEMAND

A Scientific and Risk Based Approach to Pediatric Formulations

Stuart Charlton
Bristol-Myers Squibb

 

VIEW ON DEMAND

Regulatory Considerations for Pediatric Formulations

Cheenu Murti
Merck & Co., Inc.

 

VIEW ON DEMAND

Approaches for Sensory Evaluation of Medicine Palatability

Alexander Bachmanov
GlaxoSmithKline

 

VIEW ON DEMAND

Formulating Poorly Soluble Drugs for Pediatrics

Carsten Timpe
Roche

 

VIEW ON DEMAND

 


2019

Feasibility of Miniaturized Tablets as a Flexible Solid Dosage Form

Biplob Mitra, Celgene

 

VIEW ON DEMAND

Neuroscience of Medicine Palatability

Alexander Bachmanov, GlaxoSmithKline

 

VIEW ON DEMAND

Central Repository for Safety Assessment of Excipents for Pediatrics (STEP Database)

Smita Salunke, EuPFI

 

VIEW ON DEMAND

Challenges in Developing Age-appropriate Formulations for Neglected Tropical Diseases

Daniel Schaufelberger, Schaufelberger Consulting 

 

VIEW ON DEMAND

 


                                              2018

CMC Considerations for Pediatric Drug Development

Eleni Dokou, Vertex 

 

     

VIEW ON DEMAND

What is the EuPFI and What Can We Do for You?

David Clapham and Smita Salunke, EuPFI

 

     

VIEW ON DEMAND

Container Closure and Device Systems for Pediatric Combination Products

Matthew Thomas, Eli Lilly

 

 

   

VIEW SLIDE DECK

Relevance of PK (PK/PD) in Pediatric Drug Development

Sebastian Haertter, Boehringer Ingelheim

 

     

VIEW ON DEMAND

 


          2017

Development of Ritonavir Pediatric Formulations

John Morris, AbbVie

 

VIEW ON DEMAND

Extemporaneous Formulations in Pediatric Drug Development

Karen Thompson, Merck

 

VIEW ON DEMAND

Immediate Release Reverse Enteric Coated Melt-Spray-Congeal Microspheres as a Pediatric Platform

Matthew Santangelo, Pfizer

 

VIEW SLIDE DECK